Visit COVID-19 resources

[Skip to Content]

Reply to ‘Comment on: Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizmab’ – (Eye Journal AOP)

12 February 2016

This news item is available to RCOphth members only, please log in below to access.

Members Login